Vericel (VCEL) Change in Account Payables (2019 - 2026)
Vericel (VCEL) reported Change in Account Payables of $2.6 million for Q1 2026, up 570.05% on a YoY basis from $386535.8 in Q1 2025, and up 263.25% sequentially from $713000.0 in Q4 2025.
Vericel (VCEL) Change in Account Payables (2019 - 2026) Analysis & Trends
Vericel (VCEL) has 8 years of Change in Account Payables data on file, last reported at $2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 570.05% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 51.17% YoY), and the FY2025 full-year result was $3.0 million, up 1136.24% from the prior year.
- Change in Account Payables advanced to $2.6 million in Q1 2026, from $713000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $4.7 million in Q2 2024 to a low of -$4.9 million in Q1 2024.
- A 5-year average of $574294.1 and a median of $713000.0 in 2025 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables tumbled 1682.12% in 2024 and jumped 570.05% in 2026, its largest moves.
- Tracing VCEL's Change in Account Payables over 5 years: stood at $1.5 million in 2022, then soared by 82.43% to $2.7 million in 2023, then sank by 49.72% to $1.4 million in 2024, then tumbled by 47.26% to $713000.0 in 2025, then jumped by 263.25% to $2.6 million in 2026.
- Business Quant data shows VCEL's Change in Account Payables at $2.6 million in Q1 2026, $713000.0 in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 713,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 2.80 Mn |
| Sep 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -551,000.00 |
| Mar 31, 2025 | -551,000.00 |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Mar 31, 2024 | -4.88 Mn |
| Mar 31, 2024 | -4.88 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Dec 31, 2023 | 2.69 Mn |